Hesperetin induces apoptosis in gefitinib-resistant NCI-H1975 cells through ROS mediated endoplasmic reticulum stress 【IF: 0】Chinese Journal of Clinical Pharmacology and Therapeutics. 2024 Oct 24 Hesperetin purchased from AbMole
Patent. EP4455665A1 【IF: 0】Patent. EP4455665A1 2024 Oct 30 Y-27632 dihydrochloride purchased from AbMole
Patent. US12138490B2 【IF: 0】Patent. US12138490B2 2024 Nov 12 Tofacitinib purchased from AbMole
Patent. CN117706086A 【IF: 0】Patent. CN117706086A 2024 Mar 15 DAPI solution purchased from AbMole
Patent. CN118127118A 【IF: 0】Patent. CN118127118A 2024 Jun 04 Y-27632 dihydrochloride purchased from AbMole
Patent. CN118909946A 【IF: 0】Patent. CN118909946A 2024 Nov 08 Acetylcysteine (NAC) purchased from AbMole
Patent. CN117582444A 【IF: 0】Patent. CN117582444A 2024 Feb 23 Vesatolimod (GS-9620) purchased from AbMole
Patent. CN119138406A 【IF: 0】Patent. CN119138406A 2024 Dec 17 Recombinant Human GM-CSF (HEK293, C-His) purchased from AbMole
Patent. CN115058393B 【IF: 0】Patent. CN115058393B 2024 May 24 Alemtuzumab purchased from AbMole
Patent. JP2024093340A 【IF: 0】Patent. JP2024093340A 2024 Jul 09 Procyanidin B4 purchased from AbMole
Patent. TW202421658A 【IF: 0】Patent. TW202421658A 2024 Jun 01 PR-619 purchased from AbMole
Patent. US2024252687A1 【IF: 0】Patent. US2024252687A1 2024 Aug 01 XAV939 purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
